Clinical Trials

Recruiting At-Risk Women to HIV Vaccine Trials Isn't Easy

Published in AIDS Weekly, December 4th, 2000

Recruiting women to and keeping them in HIV vaccine efficacy trials is a challenge.

Workers in The New York Blood Center report that such efforts need to draw from a variety of sources and involve community agencies to be successful. They should know: 72% of the at-risk women they attempted to recruit to an HIV vaccine preparedness study rejected the opportunity to participate.

Pamela Brown-Peterside and colleagues enrolled at-risk, non-injection drug user, HIV-1 negative women into their study in the following ways:

clinics and community agencies (40%) - although they noted that most of the refusals they received also came from these...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2000-12-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry